Inhibitory effect of morphine on granulocyte stimulation by tumor necrosis factor and substance P.
We demonstrate that morphine, at higher concentrations than that effective in the inhibition of spontaneously active cells, can antagonize stimulation of human granulocytes by tumor necrosis factor (TNF) or substance P. The antagonistic effect appears to occur indirectly by way of downregulation of the cells' responsiveness to these stimulatory substances. We have previously shown that neutral endopeptidase 24.11 (NEP) is an important enzyme in neuro- and autoimmunoregulation of both vertebrates and invertebrates, and that activation of human granulocytes by monokines and neuropeptides results in regulation of NEP. Exposure of intact human granulocytes to morphine increases NEP by a naloxone-sensitive mechanism. The increased expression of NEP downregulates the stimulatory effect of substance P and TNF. In the case of substance P, we demonstrate the significance of NEP in modulating the process of downregulation by use of a specific NEP inhibitor, phosphoramidon. These results indicate that morphine is a significant factor in downregulating immunocyte responsiveness to NEP substrates and also to those signal molecules (i.e. cytokines) not metabolized by it. In summary, we infer that opiates may be endogenous signal molecules, a status that appears to be amply supported by their immunosuppressive actions.
Stefano
G B
GB
Multidisciplinary Center for the Study of Aging, State University of New York College at Old Westbury, NY 11568.
Kushnerik
V
V
Rodriquez
M
M
Bilfinger
T V
TV
D006098:Granulocytes / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D007091:Image Processing, Computer-Assisted; D066298:In Vitro Techniques; D007202:Indicators and Reagents; D008213:Lymphocyte Activation / Q000187:drug effects; D009020:Morphine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D015260:Neprilysin / Q000096:biosynthesis; D013373:Substance P / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D015854:Up-Regulation / Q000187:drug effects
D007202:Indicators and Reagents; D014409:Tumor Necrosis Factor-alpha; D013373:Substance P; D009270:Naloxone; D009020:Morphine; D015260:Neprilysin